CTLA4 and autoimmune disease: Here, we generated a synthetic chimeric peptide comprising the cytoplasmic domain of CTLA‐4 conjugated with the blood brain barrier (BBB)‐permeable peptide dNP2 to stimulate Foxp3 expression in murine and human T cells to treat autoimmune disease.